Navigation Links
S*BIO Restructures Agreement With Onyx for JAK2 Inhibitor Program
Date:5/4/2011

SINGAPORE, May 4, 2011 /PRNewswire/ -- S*BIO Pte Ltd today announced the restructuring of its collaboration and option agreement with Onyx Pharmaceuticals, which was entered into in January 2009. As a result, S*BIO has regained North American and European rights to its novel JAK2 inhibitors, SB1518 and SB1578, from Onyx.  Following a successful and productive partnership with Onyx, S*BIO will now be in a position to drive the development of its lead JAK2 program independently.

Recent data from Phase 2 clinical trials of SB1518 indicated promising clinical efficacy and good tolerability for the treatment of myelofibrosis (MF), an orphan indication with high unmet medical need.  SB1518 has also demonstrated clinical benefits in patients with relapsed/refractory lymphoma. S*BIO plans to advance SB1518 and SB1578 expeditiously through clinical development, with pivotal trials for SB1518 anticipated to begin later this year.

"Consolidating North American and European rights for SB1518 and SB1578 represents a unique opportunity for S*BIO to steer the global development of these two promising products," said Dr. Jan-Anders Karlsson, CEO of S*BIO. "Our strong relationship with Onyx has led to the successful clinical advancement of both SB1518 and SB1578.  SB1518 has now reached a critical inflection point where its future success in a highly competitive field depends on an aggressive and focused development plan. As an existing shareholder, Onyx's interests remain aligned with S*BIO's objective to maximize the value of the JAK2 program and to share in the upside potential of SB1518 and other S*BIO assets."

About S*BIO Pte LtdS*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around kinases and histone deacetylases (HDAC). SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008
'/>"/>

SOURCE S*BIO
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. S*BIO to Develop New JAK-2 Inhibitor for Treatment of Myeloproliferative Disorders and Hematological Malignancies
2. S*BIO Initiates U.S. Phase I Clinical Trials of Oral JAK2 Inhibitor SB1518 for the Treatment of Hematological Malignancies
3. S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis
4. S*BIOs JAK2 Inhibitor SB1518 Granted Orphan Drug Designation by European Commission (EC) for the Treatment of Myelofibrosis (MF)
5. S*BIOs Novel Dual mTOR/PI3 Kinase Inhibitor SB2343 Demonstrates Excellent PK/PD Properties Leading to Significant Anti-Tumor Efficacy in Xenograft Models
6. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
7. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
8. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
9. Intellect Neurosciences, Inc. and CHDI, Inc. Enter Into Compound Testing Agreement to Evaluate OXIGON(TM) as a Potential Treatment for Huntington Disease
10. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
11. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... CHARLESTON, W.Va. , July 23, 2014 /PRNewswire-iReach/ -- ... awarded a new five-state Quality Innovation Network-Quality Improvement Organization ... Virginia Medical Institute (WVMI). Effective August 1, ... West Virginia , Pennsylvania ... New Jersey and Louisiana.  The Network will ...
(Date:7/23/2014)... , July 23, 2014 Research ... the "Global Electrophysiology Ablation Catheters Market 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 Catheter ablation ... or destroy faulty electrical pathways from sections of ... known as cardiac arrhythmias). Cardiac arrhythmias can be ...
(Date:7/23/2014)... , July 23, 2014 Creekridge Capital, ... added 14 new vendors so far in 2014 ... Creekridge,s newest vendors are from both the healthcare ... organizations to large, well-known multi-national companies. Each of ... suite of financing products including: standard leasing products, ...
Breaking Medicine Technology:Announcing a New Regional Approach to Medicare Quality Improvement 2Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 2Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 3Creekridge Capital Signs Several New Vendor Partners 2
... (Nasdaq: MDRX ) announced today that it ... nine months ended September 30, 2010 after the New York ... management will host a conference call and webcast to ... PM Eastern Standard Time on the same day. ...
... KNOXVILLE, Tenn., Oct.  13 The fastest-growing privately ... its business by building in-office medication dispensing programs ... just five years ago, Physicians, Pharmaceutical Corporation (PPC) ... 15 overall on the 2010 Inc. 5000 ...
Cached Medicine Technology:Allscripts to Announce Third Quarter 2010 Results on November 8, 2010 2Allscripts to Announce Third Quarter 2010 Results on November 8, 2010 3Physicians' Pharmaceutical Corporation Offers Innovative On-Site Drug Dispensaries 2
(Date:7/24/2014)... July 24, 2014 Follow us ... commonly known as food polyols, is driven by increasing ... Rising incidence of obesity, growing awareness over the benefits ... to diabetes are some of the key factors driving ... of scientific studies validating the health benefits of sweeteners, ...
(Date:7/24/2014)... Losing a husband or wife is devastating. ... as shock, fear, guilt, anger, and numbness – make the ... It may be small comfort to know that these feelings ... fact the case that grieving is a finite process. “Sadness ... Hayley Hirschmann of Morris Psychological Group , “but ...
(Date:7/24/2014)... Sunnyvale, CA (PRWEB) July 24, 2014 ... of high throughput research solutions for biopharmaceutical development, ... article “Highly Concentrated Protein Formulations” by Jim Kling. ... with highly concentrated protein formulations and how automation ... , High-concentration protein formulations have been a ...
(Date:7/24/2014)... Lighthouse Point, FL (PRWEB) July 24, 2014 ... http://www.dmcconline.org , a nonprofit credit counseling organization (DMCC), ... low cost services to help federal student loan ... U.S. Department of Education offers various repayment options ... student loans. The options available, and the corresponding ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 Imbue ... a Woman-Owned Small Business (WOSB) by the National Women ... SBA -approved third party certifier. , Located ... that collaborates with clients to drive growth through strategic ... both developing insights and activating options through teams, tools, ...
Breaking Medicine News(10 mins):Health News:Rising Incidence of Diabetes and Obesity Drives the Global Sugar Alcohols Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Rising Incidence of Diabetes and Obesity Drives the Global Sugar Alcohols Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Coping with the Loss of a Spouse: Is it Grief or Is It Depression? Dr. Hayley Hirschmann with Morris Psychological Group Provides Tips for Grieving 2Health News:Coping with the Loss of a Spouse: Is it Grief or Is It Depression? Dr. Hayley Hirschmann with Morris Psychological Group Provides Tips for Grieving 3Health News:Coping with the Loss of a Spouse: Is it Grief or Is It Depression? Dr. Hayley Hirschmann with Morris Psychological Group Provides Tips for Grieving 4Health News:Freeslate Featured in BioProcess International Article Discussing Challenges and Solutions to Highly Concentrated Protein Formulations 2Health News:Freeslate Featured in BioProcess International Article Discussing Challenges and Solutions to Highly Concentrated Protein Formulations 3Health News:Nonprofit Debt Management Credit Counseling Providing Low Cost Student Loan Help 2Health News:Nonprofit Debt Management Credit Counseling Providing Low Cost Student Loan Help 3Health News:Imbue Partners Certified as Woman-Owned Small Business 2
... , , , , ... , , LOS ANGELES, Aug. 25 A ... funding, the California AIDS Clearinghouse will close next week. The ... than 15 years, received notification from the state Office of AIDS ...
... 25, 2009) The Henry M. Jackson Foundation for ... promising Uniformed Services University of the Health Sciences doctoral ... The program, established in 1988, is comprised of two ... Fellowship. Each fellow receives a stipend and travel support. ...
... Va. -- Systematic, progressive resistance training also called ... for middle-aged and older adults to improve their health. ... in behavior, exercise, physiology, and medicine is designing a ... maintain resistance training in order to prevent diabetes. ...
... National Eye Institute (NEI) and the Food and ... conference to determine how vision-related patient-reported outcomes might ... ophthalmology. Patient-reported outcomes are being incorporated more ... of evidence strongly suggests that such patient-reported outcomes ...
... Charleen T. Chu, MD, PhD, associate professor at the ... associate professor, Massachusetts Institute of Technology, received the 2009 ... by The Ellison Medical Foundation, the grants provide funding ... potential in advancing understanding of basic aging and its ...
... , , TRAVERSE CITY, Mich., ... revenues of $1,155,000 for its third fiscal quarter ended July 31, ... same quarter of the prior year. Revenues for the nine ... the nine months ended July 31, 2008, a 3.0% decrease. ...
Cached Medicine News:Health News:Schwarzenegger's Budget Cuts Force Closure of California AIDS Clearinghouse 2Health News:Henry M. Jackson Foundation names fellowship award winners 2Health News:Researchers evaluate resistance training for diabetes prevention 2Health News:Researchers evaluate resistance training for diabetes prevention 3Health News:Ellison Medical Foundation awards more than $1 million to mid-career scientists 2Health News:Versus Technology Announces Third Quarter Results 2Health News:Versus Technology Announces Third Quarter Results 3Health News:Versus Technology Announces Third Quarter Results 4Health News:Versus Technology Announces Third Quarter Results 5Health News:Versus Technology Announces Third Quarter Results 6Health News:Versus Technology Announces Third Quarter Results 7
The vertebral body replacement (VBR) is used for the anterior thoracic and lumbar spine. It is intended for use in the thoracic and lumbar spine to replace a collapsed, damaged, or unstable vertebral...
... Ocelot stackable cage system provides anterior ... or total vertebrectomies from T1 to L5. ... Peek Carbon fiber polymer cages that are ... patient needs. The Peek Carbon fiber reinforced ...
... cage system provides anterior column support for ... from T1 to L5. The system consists ... polymer cages that are stacked to a ... Peek Carbon fiber reinforced polymer material emulates ...
... regeneration scaffold. Its highly ... ensures ideal osteoconductivity, while ... maximizes permeability even after ... most meaningful measure of ...
Medicine Products: